نتایج جستجو برای: losartan potassium
تعداد نتایج: 80989 فیلتر نتایج به سال:
directed against Kv1.5 mRNA specifically inhibit ultrarapid delayed rectifier Kþ current in cultured adult human atrial myocytes. Circ Res 1997;80:572–579. 64. Nattel S, Yue L, Wang Z. Cardiac ultrarapid delayed rectifiers: a novel potassium current family of functional similarity and molecular diversity. Cell Physiol Biochem 1999;9:217–226. 65. McClellan KJ, Goa KL. Candesartan cilexetil. A re...
Background & Aims: Losartan is a non-peptide potent antihypertensive agent that acts through blocking angiotensin II receptors. Hyzaar® is a combination product that contains two drugs, losartan and hydrochlorothiazide, used to lower high blood pressure. There are some reports regarding simultaneous measurement of the drugs in pharmaceutical and biological samples which includes HPLC, CE, CEC, ...
Article history: Received on: 02/03/2013 Revised on: 29/03/2013 Accepted on: 15/04/2013 Available online: 12/05/2013 This study is an investigation of the physicochemical interaction of Losartan potassium (LST K), an angiotensinII receptor (type AT1) antagonist, with micelles of triton X, a nonionic surfactant. The effect of micelles on the spectral properties of LSTK was monitored on at pH 7.4...
Design and in vitro evaluation of compression-coated pulsatile release tablets of losartan potassium
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید